Advanced Polymers and Lipids Director
Seqens
Chatenay-Malabry, France
Pharmacist and Ph.D. in pharmaceutical technology, Gregory’s carrier is split between Biotech and Pharma where he occupied the positions of Chief Scientific Officer and Chief Executive Officer and board member in companies such as Novagali, Septodont and TargEDys. He his inventor of the cationic ophthalmic emulsions technology used in Retaine MGD, Cationorm and Verkazia. He drove the development of a several drugs, medical devices and food supplement from the idea to the market. Gregory raised more than 70 m€ of venture capital funds during his carrier, did M&A both on acquisition and selling side and worked on an IPO. In May 2024, Gregory joined Seqens as Director for Drug Delivery Solutions Business line.
Disclosure information not submitted.
Tech Forum Nanomedicines From Where Are We Coming and Where Are We Going
Thursday, July 11, 2024
8:00 AM – 9:00 AM CET
